The Power of Stem Cells | California’s Stem Cell Agency

En Espaol Stem cells have the potential to treat a wide range of diseases. Here, discover why these cells are such a powerful tool for treating diseaseand what hurdles experts face before new therapies reach patients. How can stem cells treat disease?What diseases could be treated by stem cell research?How can I learn more about CIRM-funded research in a particular disease?What cell therapies are available right now?What about the therapies that are available overseas?Why does it take so long to create new therapies?How do scientists get stem cells to specialize into different cell types

Read more
HUB Organoids are the key to advancing cancer therapies – SelectScience

Dr. Sylvia Boj discusses the advantages of organoids and how these 3D tissue cultures have enormous potential to revolutionize how we treat patients and predict therapeutic response In this exclusive interview, we speak with Dr. Sylvia Boj, Chief Research Officer at Hubrecht Organoid Technology (HUB), to find out how patient-derived organoids are becoming promising models for personalized treatment.

Read more
Volunteer Pilots Help Be the Match During Coronavirus Pandemic – AviationPros.com

This past March, Be The Match enlisted Air Care Alliances (ACA) vast network of volunteer pilot organizations to deliver life-saving blood stem cells to patients with blood cancerslike leukemia and lymphomanationwide. At that time, it was thought that a decrease in commercial flights and volunteer availability would disrupt distribution of the blood stem cells

Read more
MicroCures Announces Issuance of New European Patent Providing Broad Protection for First-of-its-Kind Cell Movement Decelerator Technology – Yahoo…

Latest Patent Further Strengthens Intellectual Property Portfolio Covering Novel Platform for Precisely Controlling Core Cell Migration Mechanisms Decelerator Technology Has Key Potential Applications in Treatment of Cancer and Fibrosis and Serves as Key Complement to Companys Cell Motility Accelerator Platform for Enhanced Tissue Repair NEW YORK, May 20, 2020 (GLOBE NEWSWIRE) -- MicroCures, a biopharmaceutical company developing novel therapeutics that harness the bodys innate regenerative mechanisms to accelerate tissue repair, today announced the issuance of a new European patent providing broad protection for the companys first-of-its-kind cell movement decelerator technology, which has potential therapeutic applications in combating cancer metastases and fibrosis. The companys decelerator technology is being developed alongside MicroCures accelerator technology, which is designed to enhance repair of tissue, nerves, and organs following trauma. With the newly issued patent in the European Union (#3052117), the companys global patent estate now includes eight issued and 12 pending patents covering its underlying technology, as well as the therapeutic programs that have emerged from the platform

Read more